You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Microsatellite stability

Showing 1 - 25 of 2,819
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

MSS, pMMR, Metastatic Colorectal Adenocarcinoma Trial in Shenyang (TKI ± anti-PD-1 antibody)

Recruiting
  • MSS
  • +2 more
  • TKI ± anti-PD-1 antibody
  • Shenyang, Liaoning, China
    Cancer Hospital of China Medical University/Liaoning Cancer Hosp
Sep 28, 2021

Colorectal Cancer, Immunotherapy Trial in Guangzhou (mFOLFOX6+Bevacizumab+PD-1 mAb treatment combinations)

Recruiting
  • Colorectal Cancer
  • Immunotherapy
  • mFOLFOX6+Bevacizumab+PD-1 monoclonal antibody treatment combinations
  • Guangzhou, Guangdong, China
    Sun Yatsen University
May 19, 2021

Microsatellite Stable (MSS) Colorectal Adenocarcinomas, Colorectal Adenocarcinoma Trial in Baltimore (Nivolumab, Relatlimab)

Recruiting
  • Microsatellite Stable (MSS) Colorectal Adenocarcinomas
  • Colorectal Adenocarcinoma
  • Baltimore, Maryland
    Sidney Kimmel Comprehensive Cancer Center
Mar 14, 2022

Microsatellite Instability in Colorectal Cancers

Completed
  • Colorectal Cancer
  • +4 more
  • Microsatellite instability analysis
  • Istanbul, Turkey
    Sultan 2. Abdulhamid Training and Research Hospital
Dec 5, 2021

Colorectal Cancer, Mismatch Repair-deficient (dMMR), Microsatellite Instability-high (MSI-H) Trial in ZhengZhou (Cadonilimab

Not yet recruiting
  • Colorectal Cancer
  • +3 more
  • Cadonilimab (®), a PD-1/CTLA-4 bi-specific antibody
  • ZhengZhou, Henan, China
    Henan Cancer Hospital/The affiliated Cancer Hospital of ZhengZho
Jun 18, 2023

Endometrial Carcinoma, Tumor Molecular Features Screening Model Trial (open surgery, laparoscopic surgery)

Not yet recruiting
  • Endometrial Carcinoma
  • Tumor Molecular Features Screening Model
  • open surgery
  • laparoscopic surgery
  • (no location specified)
Jun 7, 2023

Metastatic Colorectal Cancer, BRAF V600E Mutation Positive Trial in France (Collection of blood samples)

Not yet recruiting
  • Metastatic Colorectal Cancer
  • BRAF V600E Mutation Positive
  • Collection of blood samples
  • Avignon, France
  • +26 more
Nov 25, 2022

MSS, Rectal Cancer Trial (Sintilimab with Interleukin-2)

Not yet recruiting
  • MSS
  • Rectal Cancer
  • Sintilimab with Interleukin-2
  • (no location specified)
Nov 1, 2023

Gastric Cancer Trial (Sintilimab)

Not yet recruiting
  • Gastric Cancer
  • (no location specified)
Oct 21, 2022

Esophageal Squamous Cell Carcinoma, Esophageal Adenocarcinoma, Gastroesophageal Junction Adenocarcinoma Trial in Duarte, South

Withdrawn
  • Esophageal Squamous Cell Carcinoma
  • +2 more
  • Duarte, California
  • +2 more
Feb 21, 2022

Colonic Tumors, Neoadjuvant Therapy, Immune Checkpoint Inhibitors Trial in Nanning (Tislelizumab, Oxaliplatin, Capecitabine)

Recruiting
  • Colonic Neoplasms
  • +2 more
  • Nanning, Guangxi, China
    The First Affiliated Hospital of Guangxi Medical University
Nov 9, 2023

Clinical Stage I Gastroesophageal Junction Adenocarcinoma AJCC v8, Clinical Stage II Gastroesophageal Junction Adenocarcinoma

Recruiting
  • Clinical Stage I Gastroesophageal Junction Adenocarcinoma AJCC v8
  • +18 more
  • Duarte, California
    City of Hope Medical Center
Feb 16, 2022

Pabolizumab for Neoadjuvant Immunotherapy of Locally Advanced

Recruiting
  • Gastric Cancer
  • Gastric Adenocarcinoma
  • Beijing, Beijing, China
    Beijing Cancer Hospital
Apr 4, 2023

Colorectal Cancer Trial in Harbin (AK119, AK112, Oxaliplatin)

Not yet recruiting
  • Colorectal Cancer
  • Harbin, China
    Cancer Hospital Affiliated to Harbin Medical University
May 5, 2023

Endometrial Cancer Trial in Paris (cervical cytology during surgery.)

Not yet recruiting
  • Endometrial Cancer
  • cervical cytology during surgery.
  • Paris, France
    Medical genetics department
Feb 22, 2023

Colorectal Cancer, Gastric Cancer, Oesophageal Cancer Trial in Belgium, Italy, Spain (Hepatic Biopsy, BO-112 with Pembrolizumab)

Recruiting
  • Colorectal Cancer
  • +2 more
  • Hepatic Biopsy
  • BO-112 with Pembrolizumab
  • Brussels, Belgium
  • +11 more
Dec 8, 2020

CCR5, Microsatellite Stable, Metastatic Trial (700mg leronlimab weekly dose, 80mg Regorafenib at week 1, 120mg Regorafenib at

Withdrawn
  • CCR5
  • +3 more
  • 700mg leronlimab weekly dose
  • +3 more
  • (no location specified)
Feb 15, 2023

MSI-H/dMMR Gastroesophageal-junction Cancer, MSI-H/dMMR Gastric Cancer Trial (S095029, Pembrolizumab 200 mg)

Not yet recruiting
  • MSI-H/dMMR Gastroesophageal-junction Cancer
  • MSI-H/dMMR Gastric Cancer
  • (no location specified)
Oct 30, 2023

Colorectal Cancer Trial in Omaha (XL092, Atezolizumab, Regorafenib)

Recruiting
  • Colorectal Cancer
  • Omaha, Nebraska
    Exelixis Clinical Site #1
Jul 26, 2022

Metastatic Microsatellite-stable Colorectal Cancer Trial in China (Experimental drug, Control Rx)

Recruiting
  • Metastatic Microsatellite-stable Colorectal Cancer
  • Experimental drug
  • Control Rx
  • Hefei, Anhui, China
  • +11 more
Mar 13, 2023

Colorectal Liver Metastases Trial in Nanjing (Radiation: High- and Low-dose radiotherapy, PD-1 Inhibitors)

Recruiting
  • Colorectal Liver Metastases
  • Radiation: High- and Low-dose radiotherapy
  • PD-1 Inhibitors
  • Nanjing, Jiangsu, China
    Jiangsu Cancer Hospital
Sep 13, 2023

Colonic Tumors Trial (Dostarlimab, CAPEOX, FOLFOX)

Not yet recruiting
  • Colonic Neoplasms
  • Dostarlimab
  • +2 more
  • (no location specified)
May 3, 2023

pMMR, MSS, MSI-L Trial (Serplilumab, Capecitabine, Oxaliplatin)

Not yet recruiting
  • pMMR
  • +3 more
  • (no location specified)
Feb 19, 2023

New Patient Stratification Tools in MSS RAS mt mCRC

Completed
  • Advanced Colorectal Cancer
    • Heidelberg, Germany
    • +9 more
    Nov 25, 2022

    Refractory Metastatic Colorectal Cancer, pMMR, MSS Trial in United States (RP2, RP3, atezolizumab)

    Not yet recruiting
    • Refractory Metastatic Colorectal Cancer
    • +2 more
    • RP2
    • +3 more
    • Los Angeles, California
    • +5 more
    Feb 24, 2023